Phlow Corp. Obligated $696.7 Million Under HHS Contract for Domestic Active Pharmaceutical Ingredient Manufacturing
The Department of Health and Human Services has obligated $696,665,954 to Phlow Corp. under a contract for domestic advanced manufacturing of active pharmaceutical ingredients, supporting essential medicines and future public health threats.
FMG Newsroom